These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12513665)

  • 1. ECVAM's activities on computer modelling and integrated testing.
    Worth AP
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():133-7. PubMed ID: 12513665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a testing strategy for detecting embryotoxic hazards of chemicals in vitro by using embryonic stem cell models.
    Bremer S; Pellizzer C; Adler S; Paparella M; de Lange J
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():107-9. PubMed ID: 12513659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECVAM's research and validation activities in the fields of topical toxicity and human studies.
    Zuang V
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():119-23. PubMed ID: 12513662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status and future applicability of quantitative structure-activity relationships (QSARs) in predicting toxicity.
    Cronin MT
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():81-4. PubMed ID: 12513655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECVAM's activities on biologicals.
    Halder M; Balls M; Hendriksen C; Cussler K
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():125-8. PubMed ID: 12513663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECVAM's response to the changing political environment for alternatives: consequences of the European Union chemicals and cosmetics policies.
    Hartung T; Bremer S; Casati S; Coecke S; Corvi R; Fortaner S; Gribaldo L; Halder M; Roi AJ; Prieto P; Sabbioni E; Worth A; Zuang V
    Altern Lab Anim; 2003 Nov; 31(5):473-81. PubMed ID: 15598174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECVAM's role in the implementation of the Three Rs concept in the field of biologicals.
    Hendriksen C; Cussler K; Halder M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():41-6. PubMed ID: 12513650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):45-63. PubMed ID: 18333714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of ECVAM: a personal perspective.
    Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():239-41. PubMed ID: 12513683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():91-109. PubMed ID: 19025334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intelligent testing strategies for chemicals testing -- a case of more haste, less speed?
    Combes R; Balls M
    Altern Lab Anim; 2005 Jun; 33(3):289-97. PubMed ID: 16180981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECVAM's collaborations with academia.
    Clothier R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():175-83. PubMed ID: 12513670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future activities: ECVAM and the quality control of biologicals.
    Cussler K; Halder M; Hendriksen C
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():225-6. PubMed ID: 12513681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation.
    Gerner I; Liebsch M; Spielmann H
    Altern Lab Anim; 2005 Jun; 33(3):215-37. PubMed ID: 16180977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating (Q)SAR models, expert systems and read-across approaches for the prediction of developmental toxicity.
    Hewitt M; Ellison CM; Enoch SJ; Madden JC; Cronin MT
    Reprod Toxicol; 2010 Aug; 30(1):147-60. PubMed ID: 20006701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSARs in ecotoxicological risk assessment.
    de Roode D; Hoekzema C; de Vries-Buitenweg S; van de Waart B; van der Hoeven J
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):24-35. PubMed ID: 16529851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52.
    Netzeva TI; Worth A; Aldenberg T; Benigni R; Cronin MT; Gramatica P; Jaworska JS; Kahn S; Klopman G; Marchant CA; Myatt G; Nikolova-Jeliazkova N; Patlewicz GY; Perkins R; Roberts D; Schultz T; Stanton DW; van de Sandt JJ; Tong W; Veith G; Yang C
    Altern Lab Anim; 2005 Apr; 33(2):155-73. PubMed ID: 16180989
    [No Abstract]   [Full Text] [Related]  

  • 20. ECVAM's in-house prevalidation/validation studies in the areas of haematotoxicity, reproductive toxicity, metabolism-mediated toxicity and epithelial barrier function.
    Prieto P
    Sci Total Environ; 2000 Mar; 247(2-3):349-54. PubMed ID: 10803561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.